Clinical Trials Logo

Clinical Trial Summary

Ιn the present study (BIOEPI), the following three hypotheses will be investigated: 1. The proposed TMS-EEG / EMG protocol (which includes software for calculating the cerebral cortex stimulation threshold) in combination with advanced signal analysis and data mining methods will allow the detection of the effect of antiepileptic drugs (AED) with different mechanisms of action (lacosamide & brivaracetam) in the Central Nervous System under healthy and pathological conditions (Epilepsy). 2. AED-induced changes in selected TMS-EEG / EMG features predict the clinical response of individual epileptic patients to AED. 3. AED-induced changes in selected TMS-EEG / EMG features may predict cognitive side effects.


Clinical Trial Description

The overarching objective of this study is to develop a combined TMS-EEG/EMG protocol so as to explore the effects of AEDs on cortical excitability and obtain novel electrophysiological biomarkers which could help predict the response of epileptic patients to AEDs, in line with the principles of personalized medicine. In order to achieve the overarching objective, we will perform a Diagnostic Clinical Performance Study, (FDA 2013) with the following specific objectives. Primary Objective 1: To investigate whether TMS-EEG/EMG biomarkers can predict the response of patients with focal epilepsy to AEDs (Lacosamide & Brivaracetam). Secondary Objective 1: Development, testing and validation of novel TMS-EEG/EMG stimulation and multi-level data analysis protocols, incorporating advanced methods of signal analysis, connectivity, complexity, and propagation across the cortical mantle. Secondary Objective 2: Investigating the sensitivity of TMS-EEG/EMG biomarkers for detecting changes in brain physiology in healthy subjects and patients with focal epilepsy.Secondary Objective 3: Investigating whether TMS-EEG / EMG biomarkers may predict cognitive deficits in patients with focal epilepsy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05278221
Study type Interventional
Source Aristotle University Of Thessaloniki
Contact Vasilios Kimiskidis, Professor
Phone +30-2310-994667
Email kimiskid@auth.gr
Status Recruiting
Phase N/A
Start date August 1, 2022
Completion date March 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02245061 - Cortical Excitability Assessment Using Paired Pulses N/A
Terminated NCT05081518 - A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy Phase 1
Withdrawn NCT05481905 - ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures Phase 2
Completed NCT02208492 - The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study Phase 4
Recruiting NCT04839601 - RNS System RESPONSE Study N/A
Completed NCT02898935 - Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
Enrolling by invitation NCT05748236 - The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy Phase 4
Terminated NCT01724918 - Lacosamide IV and EEG/EKG (LIVE) Study Phase 2
Completed NCT00855738 - A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice Phase 4
Recruiting NCT06309966 - Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Phase 2/Phase 3
Not yet recruiting NCT06210022 - Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
Completed NCT01311440 - Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy N/A
Terminated NCT03955432 - Long-term Cardiac Monitoring in Epilepsy N/A
Recruiting NCT06132893 - A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Phase 2/Phase 3
Recruiting NCT05100771 - Optimized Volumetry in Radiology: Interest in Pediatric Brain MRI in the Exploration of Focal Epilepsy
Recruiting NCT04879433 - Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05198882 - Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy Phase 1
Recruiting NCT05981755 - Breathing Rescue for SUDEP Prevention N/A
Recruiting NCT03457961 - Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong